A novel serum metabolomics-based diagnostic approach for colorectal cancer

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Nishiumi, Shin ^a   Kobayashi, Takashi ^a   Ikeda, Atsuki ^a   Yoshie, Tomoo ^a   Kibi, Megumi ^a   Izumi, Yoshihiro ^a   Okuno, Tatsuya ^a   Hayashi, Nobuhide ^b   Kawano, Seiji ^b   Takenawa, Tadaomi ^a   Azuma, Takeshi ^a   Yoshida, Masaru ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KOBE UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2 HYDROXYBUTYRIC ACID; ARABINOSE; ASPARAGINE; ASPARTIC ACID; BETA ALANINE; CA 19-9 ANTIGEN; CITRULLINE; CREATININE; CYSTAMINE; CYSTINE; ERYTHRITOL; GLUCURONIC ACID; GLUCURONIC ACID 1; GLUCURONIC ACID 2; GLUTAMIC ACID; HYDROXYBUTYRIC ACID; INOSITOL; ISOLEUCINE; KYNURENINE; LACTITOL; NONANOIC ACID; ORNITHINE; PALMITOLEIC ACID; PHOSPHATE; PHOSPHOETHANOLAMINE; PYROGLUTAMIC ACID; PYRUVIC ACID; UNCLASSIFIED DRUG; XYLITOL;

ADULT; AGE; AGED; AREA UNDER THE CURVE; ARTICLE; BODY MASS; CANCER LOCALIZATION; CANCER PATIENT; CANCER STAGING; COLORECTAL CANCER; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MASS FRAGMENTOGRAPHY; METABOLITE; METABOLOMICS; METHODOLOGY; MODEL; SENSITIVITY AND SPECIFICITY; SEX; VALIDITY;

ADULT; AGED; AGED, 80 AND OVER; AREA UNDER CURVE; ASPARTIC ACID; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; CYSTAMINE; EARLY DETECTION OF CANCER; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; HYDROXYBUTYRATES; KYNURENINE; LOGISTIC MODELS; MALATES; MALE; METABOLOMICS; MIDDLE AGED; MULTIVARIATE ANALYSIS; REFERENCE STANDARDS; ROC CURVE; STATISTICS, NONPARAMETRIC; TUMOR MARKERS, BIOLOGICAL;

EID: 84863844396     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0040459     Document Type: Article

References (28)

1. Siegel R, Naishadham D, Jemal A, (2012) Cancer statistics 2012. CA Cancer J Clin 62: 10-29.
2. Matsuda T, Marugame T, Kamo K, Katanoda K, Ajiki W, et al. (2010) Cancer incidence and incidence rates in Japan in 2004: based on data from 14 population based cancer registries in the Monitoring of Cancer Incidence in Japan (MCIJ) project. Jpn J Clin Oncol 40: 1192-1200.
3. Petricoin EF, Ardekani AM, Hitt BA, Levine PJ, Fusaro VA, et al. (2002) Use of proteomic patterns in serum to identify ovarian cancer. Lancet 359: 572-527.
4. Sreekumar A, Poisson LM, Rajendiran TM, Khan AP, Cao Q, et al. (2009) Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature 457: 910-914.
5. Hirayama A, Kami K, Sugimoto M, Sugawara M, Toki N, et al. (2009) Quantitative metabolome profiling of colon and stomach cancer microenvironment by capillary electrophoresis time-of-flight mass spectrometry. Cancer Res 69: 4918-4925.
6. Yoshida M, Hatano N, Nishiumi S, Irino Y, Izumi Y, et al. (2012) Diagnosis of gastroenterological diseases by metabolome analysis using gas chromatography-mass spectrometry. J Gastroenterol 47: 9-20.
7. Nishiumi S, Shinohara M, Ikeda A, Yoshie T, Hatano N, et al. (2010) Serum metabolomics as a novel diagnostic approach for pancreatic cancer. Metabolomics 6: 518-528.
8. Tsugawa H, Bamba T, Shinohara M, Nishiumi S, Yoshida M, et al. (2011) Practical non-targeted gas chromatography/mass spectrometry-based metabolomics platform for metabolic phenotype analysis. J Biosci Bioeng 112: 292-298.
9. Tsugawa H, Tsujimoto Y, Arita M, Bamba T, Fukusaki E, (2011) GC/MS based metabolomics: development of a data mining system for metabolite identification by using soft independent modeling of class analogy (SIMCA). BMC Bioinformatics 12: 131.
10. Iob V, Mcmath M, Coon WW, (1963) Intra-individual and inter individual variations in plasma free amino acids in normal adults. J Surg Res 3: 85-89.
11. Demling J, Langer K, Wörthmüller M, Yusufu V, (1993) Individual day-to-day variations in plasma amino acid levels in healthy persons. Amino Acids 5: 253-262.
12. Lavie L, Lavie P, (2004) Daily rhythms in plasma levels of homocysteine. J Circadian Rhythms 2: 5.
13. Qiu Y, Cai G, Su M, Chen T, Zheng X, et al. (2009) Serum metabolite profiling of human colorectal cancer using GC-TOFMS and UPLC-QTOFMS. J Proteome Res 8: 4844-4850.
14. Kikuchi Y, Momose E, Kizawa I, Kuki E, Kato K, (1985) Elevated serum alpha-hydroxybutyrate dehydrogenase in patients with ovarian carcinoma. Acta Obstet Gynecol Scand 64: 553-556.
15. Gall WE, Beebe K, Lawton KA, Adam KP, Mitchell MW, et al. (2010) α-Hydroxybutyrate is an early biomarker of insulin resistance and glucose intolerance in a nondiabetic population. PLoS One 5, e10883.
16. Rainesalo S, Keränen T, Palmio J, Peltola J, Oja SS, et al. (2004) Plasma and cerebrospinal fluid amino acids in epileptic patients. Neurochem Res 29: 319-324.
17. Fonteh AN, Harrington RJ, Tsai A, Liao P, Harrington MG, et al. (2007) Free amino acid and dipeptide changes in the body fluids from Alzheimer's disease subjects. Amino Acids 32: 213-224.
18. Denkert C, Budczies J, Weichert W, Wohlgemuth G, Scholz M, et al. (2008) Metabolite profiling of human colon carcinoma-deregulation of TCA cycle and amino acid turnover. Mol Cancer 7, 72.
19. Chan EC, Koh PK, Mal M, Cheah PY, Eu KW, et al. (2009) Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS). J Proteome Res 8, 352-361.
20. Miyagi Y, Higashiyama M, Gochi A, Akaike M, Ishikawa T, et al. (2011) Plasma free amino acid profiling of five types of cancer patients and its application for early detection. PLoS One 6: e24143.
21. Bertini I, Cacciatore S, Jensen BV, Schou JV, Johansen JS, et al. (2012) Metabolomic NMR fingerprinting to identify and predict survival of patients with metastatic colorectal cancer. Cancer Res 72, 356-364.
22. Kimura T, Noguchi Y, Shikata N, Takahashi M, (2009) Plasma amino acid analysis for diagnosis and amino acid-based metabolic networks. Curr Opin Clin Nutr Metab Care 12: 49-53.
23. Huang A, Fuchs D, Widner B, Glover C, Henderson DC, et al. (2002) Serum tryptophan decrease correlates with immune activation and impaired quality of life in colorectal cancer. Br J Cancer 86: 1691-1696.
24. Walczak K, Da{ogonek}browski W, Langner E, Zgrajka W, Piłat J, et al. (2011) Kynurenic acid synthesis and kynurenine aminotransferases expression in colon derived normal and cancer cells. Scand J Gastroenterol 46: 903-912.
25. Herbst A, Rahmig K, Stieber P, Philipp A, Jung A, et al. (2011) Methylation of NEUROG1 in serum is a sensitive marker for the detection of early colorectal cancer. Am J Gastroenterol 106: 1110-1118.
26. Tagi T, Matsui T, Kikuchi S, Hoshi S, Ochiai T, et al. (2010) Dermokine as a novel biomarker for early-stage colorectal cancer. J Gastroenterol 45: 1201-1211.
27. Ritchie SA, Ahiahonu PW, Jayasinghe D, Heath D, Liu J, et al. (2010) Reduced levels of hydroxylated, polyunsaturated ultra long-chain fatty acids in the serum of colorectal cancer patients: implications for early screening and detection. BMC Med 8: 13.
28. Dunn WB, Broadhurst D, Begley P, Zelena E, Francis-McIntyre S, et al. (2011) Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry. Nature Protoc 6: 1060-1083.